- 1Department of Clinical Laboratory, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China
- 2School of Environment and Health, Jianghan University, Wuhan, China
Introduction: There is clinical evidence that the fresh blood viscosity is an important indicator in the development of vascular disorder and coagulation. However, existing clinical viscosity measurement techniques lack the ability to measure blood viscosity and replicate the in-vivo hemodynamics simultaneously.
Methods: Here, we fabricate a novel digital device, called Tesla valves and ultrasound waves-powered blood plasma viscometer (TUBPV) which shows capacities in both viscosity measurement and coagulation monitoring.
Results: Based on the Hagen-Poiseuille equation, viscosity analysis can be faithfully performed by a video microscopy. Tesla-like channel ensured unidirectional liquid motion with stable pressure driven that was triggered by the interaction of Tesla valve structure and ultrasound waves. In few seconds the TUBPV can generate an accurate viscosity profile on clinic fresh blood samples from the flow time evaluation. Besides, Tesla-inspired microchannels can be used in the real-time coagulation monitoring.
Discussion: These results indicate that the TUBVP can serve as a point-of-care device in the ICU to evaluate the blood’s viscosity and the anticoagulation treatment.
Introduction
Hemodynamics constitutes the comprehensive investigation of fluid dynamics within the circulatory system (Jain et al., 2016; Zhang et al., 2022; Tyagi et al., 2022). The precise characterization of flow behaviors plays a pivotal role in the realms of diagnosing and treating conditions associated with the circulatory system (Ferro et al., 2004; Mandal, 2005; Foley et al., 2012; Chen et al., 2023). Viscosity is possibly the most important parameter to characterize the different phenomena observed in blood flow (Bodnár et al., 2011; Rubio et al., 2022; Jędrzejczak et al., 2023). Usually, the increase of blood viscosity is regarded as the risk for the abnormally elevated blood flow resistance, such as in chronic vascular disease, and endothelial dysfunction (Valeanu et al., 2021; Al-kuraishy et al., 2022; De Leonardis et al., 2022; Wen et al., 2022). Acute physical exercise even causes a 10% increase of blood viscosity (El-Sayed et al., 2005; Connes et al., 2012). Besides, acute assessment of coagulopathy is important for the clinical judgement of anticoagulation drug treatment in diseases like thrombosis or bleeding (Ganter and Hofer, 2008; Carroll et al., 2009; Munoz et al., 2009; Chen et al., 2022). However, current viscometers are limited in their singular focus on viscosity measurements and lack the ability to replicate the in vivo hemodynamics accurately (Saha et al., 2021; Fuiano et al., 2022; Yi et al., 2022). Thus, there is a critical need to develop new strategy that enables rapid measurements of blood viscosity and continuous monitoring the coagulopathy simultaneously.
Inspired by Tesla valves, invented by Nikola Tesla, here we design a blood plasma viscometer that can also monitor the coagulopathy. Tesla-inspired microchannels not only can be used as fluidic diodes that allow fluid to pass easily in forward direction while resist the fluid to flow in the reverse direction (Nguyen et al., 2021; Bohm et al., 2022; Li et al., 2023), also can be employed in designs for real-time flow monitoring (Groisman and Quake, 2004; Hong et al., 2004; Hossain et al., 2010; Zhang et al., 2016; Ting et al., 2019; Wang et al., 2022). With the constant pressure driven, the flow shows stable flowing velocity, underscoring its potential for deployment in capillary-type viscometer (Kang et al., 2019; Bhattad, 2023). In addition, the Tesla-like microchannel can mimic the physiological shear rates in blood flows, providing a more faithful platform for analyzing the coagulopathy. Notably, the conventional flow driver in microfluidic viscometers, typically a peristaltic pump, is both cost-intensive, and space-, blood-consuming, showing difficulty in the point-of-care testing (Leach et al., 2003; Xie et al., 2004; Collins et al., 2016; Davis et al., 2021). Thus, a miniaturized and user-friendly platform is supposed to be developed for the microfluidic pumping in the clinic.
Acoustic streaming implemented in microfluidics has triggered various applications, such as mixing, particle manipulation, droplet manipulation, and flow control (Ding et al., 2013; Guo et al., 2015a; Guo et al., 2015b; Guo et al., 2015c; Collins et al., 2017; Hu et al., 2020; Ao et al., 2022; Zhang et al., 2022; Durrer et al., 2022; Wu et al., 2022; Wu et al., 2023a; Wu et al., 2023b; Del Campo Fonseca et al., 2023; Xu et al., 2023). Among these applications, acoustic streaming-induced fluid pumping shows the excellent properties including miniaturization, contactless, precise, stability, and tunability, which has been integrated into the point-of-care usages (Du et al., 2009; Dentry et al., 2014; Huang et al., 2014; Wu et al., 2019; Cai et al., 2020). These features indicate the great potential of acoustic streaming-induced pumping integrated into the designated microchannel. Thus, the integration of acoustic streaming and the Tesla-like microchannel would result in a new blood viscometer that has real-time monitoring functions.
In this work, we establish a simple and reliable platform for measuring blood plasma viscosity and monitoring coagulopathy, as shown in Figure 1A. This platform consists of the Tesla valve-based microchannel and ultrasound wave generator. The mechanism of viscosity measurements is similar to that in the capillary-type viscometer. The flow is driven by the acoustic streaming from the ultrasound-structure interaction. Besides, the flow direction is regulated by the Tesla-like structure’s fluid diode. Further, we demonstrate that the viscometer capability based on the Tesla valves and ultrasound waves. Benefited from the controllability of the ultrasound waves, the flow behavior can be programmed and further used to mimic the coagulopathy. These results indicate that the significant potential in the point-of-care blood viscosity and coagulopathy management.
![www.frontiersin.org](https://www.frontiersin.org/files/Articles/1394373/fbioe-12-1394373-HTML/image_m/fbioe-12-1394373-g001.jpg)
Figure 1. Design and working principle of the blood viscometer. (A) Schematics of blood viscometer, including two key components, Tesla valves and ultrasound wave generator. The viscosity of liquid can be calculated by the flowing time from position A to (B) (B) The scanning electron microscope (SEM) images showing the design of Tesla valve. W-valve width, L-length of the valve straight segment, α-leaving angle, β-returning angle (Scale bar: 200 μm). (C) Schematics of the Tesla valves and ultrasound waves-powered blood plasma viscometer (TUBPV) for measuring the viscosity of patient blood plasma.
Results
Device design and working principle. The Tesla valves and ultrasound waves-powered blood plasma viscometer (TUBPV) consists of a piezoelectric transducer and a channel with Tesla valve structures (Supplementary Figure S1), showing the stable, fast, disposable, small-volume, and precise measurement properties. This capillary-type viscometer supports visual measurements of liquids’ viscosity proportional to the flowing time under a constant distance, referring to the following Hagen-Poiseuille equation (Prusa, 2008):
where
Performance of the Tesla valve’s conduit. To access the regulation of the Tesla valve conduit on the liquid flows, we introduced liquids in the forward and reverse directions, respectively (Figures 2A,B). The relative streakline visualization reflected the effects of the conduit structures on flow acceleration and deceleration (Supplementary Movie S2 and Supplementary Movie S3). Using the same pressure as liquid propulsion, flow rates under two directions inside the conduit were significantly different (Figure 2C). The equivalent pressure values also indicated that the unique structures of Tesla valve have diodic behavior (Figure 2D). Besides, we quantified the hydrodynamic resistance
![www.frontiersin.org](https://www.frontiersin.org/files/Articles/1394373/fbioe-12-1394373-HTML/image_m/fbioe-12-1394373-g002.jpg)
Figure 2. Performance of the Tesla valve’s conduit. (A) Streakline visualization of the forward flow accelerated by the Tesla valve’s structure (Scale bar: 150 μm). (B) Streakline visualization of the reverse flow decelerated by the Tesla valve’s structure (Scale bar: 150 μm). (C) Quantification of the forward and reverse flow rate pumped by the fixed ultrasonic pressure. (D) Quantification of the pressure variation at forward and reverse flowing directions. (E) Hydrodynamic resistance versus input signal power for the forward and reverse flowing directions.
Pumping behavior powered by ultrasonic-structure interactions. We next tested and validated the unidirectional pumping powered by the ultrasonic-structure interactions using theoretical and experimental approaches. Here, the piezoelectric transducer and Tesla valve conduit were deposited on the glass substrate. Applying electric signals on the transducer, high-frequency vibrations can be generated and induce the forward and reverse pulsatile flows inside the channel. Owing the fluidic diode property of Tesla valve, the liquid pressure in reverse direction is greatly larger than that in forward direction. Consequently, stable unidirectional flow can be generated in the ultrasonic-coupled structures (Figure 3A). Under the resonant frequency, we performed the numerical simulation that showed the piezoelectric transducer can drive one-way flow inside Tesla-like channel (Figures 3B–D). Flow details in basic unit of Tesla valve showed the fluidic diodic behavior (Supplementary Figure S2). To assess the unidirectional flow, we added polystyrene beads in the liquid and recorded their movements at different time points (Figure 3E). Further, the flow rate can be precisely controlled by the input signal power, ranging from tens to hundreds of micrometers per seconds (Figure 3F). In particular, the pumping performance was programmable and repeatable by using cyclic signal stimulus (Figure 3G and Supplementary Movie S4). Thus, the digital and controllable ultrasonic stimulus ensures the reliable and stable driving force to the one-way liquid movement.
![www.frontiersin.org](https://www.frontiersin.org/files/Articles/1394373/fbioe-12-1394373-HTML/image_m/fbioe-12-1394373-g003.jpg)
Figure 3. Pumping behavior powered by ultrasonic-structure interactions. (A) Schematics of one-way liquid conduit driven by ultrasonic vibration and regulated by Tesla valve’s diodicity. (B) The working frequency of the piezoelectric transducer. (C) Acoustic pressure field in the Tesla-like channel. (D) Numerical simulation showing the flow direction inside the channel. (E) Experimental images showing the unidirectional pumping behavior in the channel by indicating the motions of polystyrene beads at different time points. Red and blue circles represent two typical groups of microbeads (Scale bar: 250 μm). (F) The pumping flow rate can be precisely controlled by tuning the input signal power. (G) The programming pumping behavior.
Validation of the blood viscometer capacity. Having validated the pumping behavior in the Tesla-like channel under the steady ultrasonic driving force, we next calibrated and verified the capacity of this ultrasound waves-powered Tesla-like channel on liquid viscosity measurements. Based on the Hagen-Poiseuille Equation 1, liquid viscosity is proportional to the flowing time from position A to B, owing to other parameters can be regarded as the constant factor (Figures 4A,B). By applying an 8-w power of electric signal on the piezoelectric transducer, steady pressure can be obtained inside the Tesla-like channel (Figure 4C). We found that the temperature in the channel was independent from the ultrasonic radiation (Supplementary Figure S3). Besides, the shear rate remained constant due to the stable flow rate, as shown in Figure 4D, indicating the accuracy on measuring liquid viscosities. Benefitting from the reliable and stable pumping performance, the ultrasound waves-powered Tesla-like channel herein acted as a proof of concept for the liquid viscosity measurement.
![www.frontiersin.org](https://www.frontiersin.org/files/Articles/1394373/fbioe-12-1394373-HTML/image_m/fbioe-12-1394373-g004.jpg)
Figure 4. Validation of the blood viscometer capacity. (A) Schematics showing the working mechanism of blood viscometer. η-viscosity, which is proportional to the flowing time from position A to B in the channel.
The calibration and verification steps need to be carried out for transforming the ultrasound waves-powered Tesla-like channel into practical viscometer. We used glycerol solutions to calibrate the viscometer performance (Figures 4E,F). When viscosity values of glycerol solutions were plotted against their concentrations, we found that they followed a sigmoidal trend. Next, five standard glycerol solutions with viscosities at 0.95 cp, 1.90 cp, 3.80 cp, 7.60 cp, and 15.2 cp were prepared following the sigmoidal fit and added into the channel (Figure 4G). Based on the relative flowing time recording, we obtained the mathematical formulation of liquid viscosity and flowing time, as shown in Figure 4H. We then experimentally tested this model by investigating flowing times of twenty kinds of liquids (Figure 4I). All the liquids data were presented in Supplementary Table S1. We found that all the results were located in the 95% confidence band of the formulation. These results indicated that the ultrasound waves-powered Tesla-like channel can serve as practical viscometer with high stability and accuracy.
Rapid hemodynamic analysis in vitro. To test the practical performance of the Tesla valves and ultrasound waves-powered blood plasma viscometer (TUBPV), we analyzed the hemodynamics including viscosity measurements of blood plasma samples and the blood coagulation monitoring. First, we measured the blood plasma viscosities by assessing the flowing time from position A to B in the empty channel (Figure 5A). Our TUBPV achieved the rapid measurement of viscosity within 10 s for each sample, avoiding the platelet aggregation. In particular, our TUBPV can distinguish the blood states in a precise manner. Figure 5B showed the accuracy of our TUBPV at 95.4% on the viscosity measurement compared with the clinical measured values. Besides, our TUBPV can monitor the coagulation status of patients in real time. Owing to the microscale and vascular-like channel, coagulation can form after long-time closed-loop flowing, as shown in Figure 5C. Collectively, our TUBPV provides a new type of viscometer that enables the precise measurement of blood plasma viscosity and the real-time monitoring of blood coagulation status simultaneously.
![www.frontiersin.org](https://www.frontiersin.org/files/Articles/1394373/fbioe-12-1394373-HTML/image_m/fbioe-12-1394373-g005.jpg)
Figure 5. Rapid hemodynamic analysis in vitro. (A) Comparison of the viscosity values between clinical and this viscometer’s results. The normal viscosity value ranges from 1.26 to 1.7 cp. (B) The accuracy result of the blood viscometer referring to 13 patient groups. The average accuracy is 95.4%. (C) The typical scanning electron micrographs showing the coagulation result.
Discussion and conclusion
We have demonstrated a novel viscometer that offers the stable, fast, disposable, small-volume, and precise measurement of blood plasma’s viscosity, providing a point-of-care method for precisely monitoring blood hemodynamics. This viscometer exploits Tesla-like flow regulator, ultrasound-based liquid pumping, and on-chip miniaturization to achieve both real-time viscosity measurements and hemodynamic analysis in vitro. This viscometer can be adapted for viscosity analysis of a range of biological fluids with the rapid feature and clear clinical implications.
The performance and capability of this Tesla valves and ultrasound waves-powered blood plasma viscometer (TUBPV) can be further improved and extended. The dimension of the Tesla-like channel could be optimized for obtaining an optimal ability in flow regulation, resulting in a more stable flow and less energy consumption. Besides, the structure and unit number of the Tesla-like channel has a great influence on the interaction with ultrasound waves. The simulated and experimental strategies could be used to improve the efficiency of ultrasound energy converted to flow motions. Furthermore, integrating miniaturized power sources, signal generator, and imaging apparatus would significantly enhance viscometer portability and practicality, such as enabling the quantification of plasma coagulation under fluid flow. Leveraging the integrated viscometer system could promote the point-of-care applications in clinic.
Methods
Fabrication of Tesla-like channel. This channel was fabricated by using maskless UV lithography (TuoTuo Technology, China) with 40 μm of layer resolution. The photocurable resin (HTL RESIN) was the functional acrylate, photo-initiator, and crosslinker, which was crosslinkable under the exposure of 405 nm light. The whole Tesla valve conduit was set as 3.5 cm
Activation of the Tesla valves and ultrasound waves-powered blood plasma viscometer. This viscometer was driven by sine radio frequency (RF) signals (working frequency, 2.06 MHz; power, 0–12.5 w) to achieve the stable flow pumping. The electric signals were controlled by a function generator (DG1022, RIGOL, China) and a power amplifier (LZY-22+, Mini-circuit, United States). By the electric stimulus, the piezoelectric transducer (PZT, Shenlei Ultrasonics, China) can generate ultrasound waves and propagated through the glass slice, and eventually interacted with the structures inside Tesla-like channel. Th high-frequency pulsatile flows can be generated in the conduit. With the regulation of the Tesla-like channel, pulsatile flows can be converted into unidirectional flows that towards the forward direction.
Simulation of the ultrasonic-powered pumping behavior. The pumping behavior was simulated via the finite element analysis (COMSOL 6.0, COMSOL Inc., Burlington, MA United States). The details can be found in the Supplementary Methods.
Preparation of Glycerol solutions. Five standard glycerol (G5516, Sigma Aldrich) solutions with viscosities at 0.95 cp, 1.90 cp, 3.80 cp, 7.60 cp, and 15.2 cp were prepared for calibrating the viscometer. Their concentrations were 0, 24, 40.2, 54.5, 62.5 % wt. All the solutions were prepared and used under the room temperature.
Preparation of blood plasma samples for viscosity measurements. Human blood plasma was obtained from Nanjing Drum Tower Hospital. All the experiments were conducted following the clinical guidelines of the Medical Clinical Research Ethics Review Form of Nanjing Drum Tower Hospital. This study was approved by the Institutional Review Board (IRB) of Nanjing Drum Tower Hospital (2022-481), Nanjing, China. Briefly, the plasma samples were used at the same time on repeated testing via commercial fully automatic hemorrheometer (Precil, ZL9 100C, China) and our viscometer. The volumes of plasma samples used in the commercial machine and our viscometer were 5 mL and 0.2 mL, respectively. Notably, Na salt at 4 mmol/L blood plasma was used as the anticoagulant, ensuring the minimal change in the plasma viscosity. All the samples were tested at the room temperature.
Ethics approval and consent to participate. This study was carried out using the blood samples and their information of 13 patients from our hospital. This study was approved by the Institutional Review Board (IRB) of Nanjing Drum Tower Hospital (approval no. 2022-481), Nanjing, China. Participants provided written informed consent prior to taking part in the study.
Characterizations. Movies were recorded by using an IX83 microscope (Olympus, Japan) with a CCD camera (DP72, Olympus, Japan). The imaging interval time of the CCD we used was 30 ms. Optical photos were obtained from a Leica stereomicroscope (M205FA, Germany). High-resolution images were acquired from a scanning electron microscope (JSM-IT200, Japan). The streakline visualization was performed in software ImageJ (Wayne Rasband, NIH). The viscosity of glycerol solutions was plotted and fitted using GraphPad Prism 10. We characterized the status of blood coagulation utilizing hydrodynamic principles, establishing a criterion whereby flow rates below 5 μL/h indicate a significant coagulation event. This decrease in flow rate is attributed to the obstruction of the microfluidic channel by coagulated blood samples. Moreover, the influence of acoustic waves on the process of blood coagulation was standardized across all experiments through the use of a consistent acoustic signal. Consequently, this standardization allows for the exclusion of ultrasound effects from the final comparative analysis of the coagulation outcomes.
Statistical analysis. The data of two comparing groups were analyzed by using the two-tailed t-test in GraphPad Prism 10. The statistical significance was denoted as:
Data availability statement
The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding authors.
Ethics statement
This study was carried out using the blood samples and their information of 13 patients from our hospital. This study was approved by the Institutional Review Board (IRB) of Nanjing Drum Tower Hospital (approval no. 2022-481), Naniing, China. Participants provided written informed consent prior to taking part in the study.
Author contributions
WC: Writing–original draft, Writing–review and editing. MX: Data curation, Supervision, Writing–review and editing. WZ: Software, Writing–review and editing. ZX: Methodology, Writing–review and editing. BC: Project administration, Writing–review and editing. HS: Funding acquisition, Resources, Writing–review and editing.
Funding
The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research was supported by the Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University (2022-LCYJ-MS-28); Jiangsu Provincial Key Research and Development Program (BE2023721); Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University (2022-LCYJ-PY-20); National Key Research and Development Program of China (SQ2023YFC2400135); Natural Science Foundation of China (61904057).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fbioe.2024.1394373/full#supplementary-material
References
Al-kuraishy, H. M., Al-Gareeb, A. I., Al-Hamash, S. M., Cavalu, S., El-Bouseary, M. M., Sonbol, F. I., et al. (2022). Changes in the blood viscosity in patients with SARS-CoV-2 infection. Front. Med. 9, 876017. doi:10.3389/fmed.2022.876017
Ao, Z., Wu, Z., Cai, H., Hu, L., Li, X., Kaurich, C., et al. (2022). Rapid profiling of tumor-immune interaction using acoustically assembled patient-derived cell clusters. Adv. Sci. 9 (22), 2201478. doi:10.1002/advs.202201478
Bhattad, A. (2023). Review on viscosity measurement: devices, methods and models. J. Therm. Analysis Calorim. 148 (14), 6527–6543. doi:10.1007/s10973-023-12214-0
Bodnár, T., Sequeira, A., and Prosi, M. (2011). On the shear-thinning and viscoelastic effects of blood flow under various flow rates. Appl. Math. Comput. 217 (11), 5055–5067. doi:10.1016/j.amc.2010.07.054
Bohm, S., Phi, H. B., Moriyama, A., Runge, E., Strehle, S., König, J., et al. (2022). Highly efficient passive Tesla valves for microfluidic applications. Microsystems Nanoeng. 8 (1), 97. doi:10.1038/s41378-022-00437-4
Cai, H., Ao, Z., Wu, Z., Nunez, A., Jiang, L., Carpenter, R. L., et al. (2020). Profiling cell-matrix adhesion using digitalized acoustic streaming. Anal. Chem. 92 (2), 2283–2290. doi:10.1021/acs.analchem.9b05065
Carroll, R. C., Craft, R. M., Langdon, R. J., Clanton, C. R., Snider, C. C., Wellons, D. D., et al. (2009). Early evaluation of acute traumatic coagulopathy by thrombelastography. Transl. Res. 154 (1), 34–39. doi:10.1016/j.trsl.2009.04.001
Chen, L., Li, D., Liu, X., Xie, Y., Shan, J., Huang, H., et al. (2022). Point-of-Care blood coagulation assay based on dynamic monitoring of blood viscosity using droplet microfluidics. ACS Sensors 7 (8), 2170–2177. doi:10.1021/acssensors.1c02360
Chen, L., Yu, L., Chen, M., Liu, Y., Xu, H., Wang, F., et al. (2023). A microfluidic hemostatic diagnostics platform: harnessing coagulation-induced adaptive-bubble behavioral perception. Cell Rep. Med. 4 (11), 101252. doi:10.1016/j.xcrm.2023.101252
Collins, D. J., Khoo, B. L., Ma, Z., Winkler, A., Weser, R., Schmidt, H., et al. (2017). Selective particle and cell capture in a continuous flow using micro-vortex acoustic streaming. Lab a Chip 17 (10), 1769–1777. doi:10.1039/c7lc00215g
Collins, D. J., Ma, Z., and Ai, Y. (2016). Highly localized acoustic streaming and size-selective submicrometer particle concentration using high frequency microscale focused acoustic fields. Anal. Chem. 88 (10), 5513–5522. doi:10.1021/acs.analchem.6b01069
Connes, P., Pichon, A., Hardy-Dessources, M., Waltz, X., Lamarre, Y., and Simmonds, M. J. (2012). Blood viscosity and hemodynamics during exerise. Clin. Hemorheol. Microcirc. 52, 101–109. doi:10.3233/CH-2011-1515
Davis, J. J., Padalino, M., Kaplitz, A. S., Murray, G., Foster, S. W., Maturano, J., et al. (2021). Utility of low-cost, miniaturized peristaltic and Venturi pumps in droplet microfluidics. Anal. Chim. Acta 1151, 338230. doi:10.1016/j.aca.2021.338230
Del Campo Fonseca, A., Glück, C., Droux, J., Ferry, Y., Frei, C., Wegener, S., et al. (2023). Ultrasound trapping and navigation of microrobots in the mouse brain vasculature. Nat. Commun. 14 (1), 5889. doi:10.1038/s41467-023-41557-3
De Leonardis, F., Colalillo, G., Finazzi Agrò, E., Miano, R., Fuschi, A., and Asimakopoulos, A. D. (2022). Endothelial dysfunction, erectile deficit and cardiovascular disease: an overview of the pathogenetic links. Biomedicines 10 (8), 1848. doi:10.3390/biomedicines10081848
Dentry, M. B., Friend, J. R., and Yeo, L. Y. (2014). Continuous flow actuation between external reservoirs in small-scale devices driven by surface acoustic waves. Lab a Chip 14 (4), 750–758. doi:10.1039/c3lc50933h
Ding, X., Li, P., Lin, S. C., Stratton, Z. S., Nama, N., Guo, F., et al. (2013). Surface acoustic wave microfluidics. Lab a Chip 13 (18), 3626–3649. doi:10.1039/c3lc50361e
Du, X. Y., Swanwick, M. E., Fu, Y. Q., Luo, J. K., Flewitt, A. J., Lee, D. S., et al. (2009). Surface acoustic wave induced streaming and pumping in 128° Y-cut LiNbO3for microfluidic applications. J. Micromechanics Microengineering 19 (3), 035016. doi:10.1088/0960-1317/19/3/035016
Durrer, J., Agrawal, P., Ozgul, A., Neuhauss, S. C. F., Nama, N., and Ahmed, D. (2022). A robot-assisted acoustofluidic end effector. Nat. Commun. 13 (1), 6370. doi:10.1038/s41467-022-34167-y
El-Sayed, M. S., Ali, N., and Ali, Z. E. (2005). Haemorheology in exercise and training. Sports Med. 35 (8), 649–670. doi:10.2165/00007256-200535080-00001
Ferro, J. M., Canhão, P., Stam, J., Bousser, M.-G., and Barinagarrementeria, F. (2004). Prognosis of cerebral vein and dural sinus thrombosis. Stroke 35 (3), 664–670. doi:10.1161/01.str.0000117571.76197.26
Foley, J. H., Petersen, K.-U., Rea, C. J., Harpell, L., Powell, S., Lillicrap, D., et al. (2012). Solulin increases clot stability in whole blood from humans and dogs with hemophilia. Blood 119 (15), 3622–3628. doi:10.1182/blood-2011-11-392308
Fuiano, F., Scorza, A., and Sciuto, S. A. (2022). Functional and metrological issues in arterial simulators for biomedical testing applications: a review. Metrology 2 (3), 360–386. doi:10.3390/metrology2030022
Ganter, M. T., and Hofer, C. K. (2008). Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth. Analgesia 106 (5), 1366–1375. doi:10.1213/ane.0b013e318168b367
Groisman, A., and Quake, S. R. (2004). A microfluidic rectifier: anisotropic flow resistance at low Reynolds numbers. Phys. Rev. Lett. 92 (9), 094501. doi:10.1103/physrevlett.92.094501
Guo, F., Li, P., French, J. B., Mao, Z., Zhao, H., Li, S., et al. (2015a). Controlling cell-cell interactions using surface acoustic waves. P Natl. Acad. Sci. U. S. A. 112 (1), 43–48. doi:10.1073/pnas.1422068112
Guo, F., Xie, Y., Li, S., Lata, J., Ren, L., Mao, Z., et al. (2015b). Reusable acoustic tweezers for disposable devices. Lab a Chip 15 (24), 4517–4523. doi:10.1039/c5lc01049g
Guo, F., Zhou, W., Li, P., Mao, Z., Yennawar, N. H., French, J. B., et al. (2015c). Precise manipulation and patterning of protein crystals for macromolecular crystallography using surface acoustic waves. Small 11 (23), 2733–2737. doi:10.1002/smll.201403262
Hong, C. C., Choi, J. W., and Ahn, C. H. (2004). A novel in-plane passive microfluidic mixer with modified Tesla structures. Lab a Chip 4 (2), 109–113. doi:10.1039/b305892a
Hossain, S., Ansari, M. A., Husain, A., and Kim, K. Y. (2010). Analysis and optimization of a micromixer with a modified Tesla structure. Chem. Eng. J. 158 (2), 305–314. doi:10.1016/j.cej.2010.02.002
Hu, X., Zhao, S., Luo, Z., Zuo, Y., Wang, F., Zhu, J., et al. (2020). On-chip hydrogel arrays individually encapsulating acoustic formed multicellular aggregates for high throughput drug testing. Lab a Chip 20 (12), 2228–2236. doi:10.1039/d0lc00255k
Huang, P.-H., Nama, N., Mao, Z., Li, P., Rufo, J., Chen, Y., et al. (2014). A reliable and programmable acoustofluidic pump powered by oscillating sharp-edge structures. Lab a Chip 14 (22), 4319–4323. doi:10.1039/c4lc00806e
Jain, A., Graveline, A., Waterhouse, A., Vernet, A., Flaumenhaft, R., and Ingber, D. E. (2016). A shear gradient-activated microfluidic device for automated monitoring of whole blood haemostasis and platelet function. Nat. Commun. 7 (1), 10176. doi:10.1038/ncomms10176
Jędrzejczak, K., Makowski, Ł., Orciuch, W., Wojtas, K., and Kozłowski, M. (2023). Hemolysis of red blood cells in blood vessels modeled via computational fluid dynamics. Int. J. Numer. Methods Biomed. Eng. 39 (11), e3699. doi:10.1002/cnm.3699
Kang, H., Jang, I., Song, S., and Bae, S.-C. (2019). Development of a paper-based viscometer for blood plasma using colorimetric analysis. Anal. Chem. 91 (7), 4868–4875. doi:10.1021/acs.analchem.9b00624
Leach, A. M., Wheeler, A. R., and Zare, R. N. (2003). Flow injection analysis in a microfluidic format. Anal. Chem. 75 (4), 967–972. doi:10.1021/ac026112l
Li, W., Yang, S., Chen, Y., Li, C., and Wang, Z. (2023). Tesla valves and capillary structures-activated thermal regulator. Nat. Commun. 14 (1), 3996. doi:10.1038/s41467-023-39289-5
Mandal, P. K. (2005). An unsteady analysis of non-Newtonian blood flow through tapered arteries with a stenosis. Int. J. Non-Linear Mech. 40 (1), 151–164. doi:10.1016/j.ijnonlinmec.2004.07.007
Munoz, S. J., Stravitz, R. T., and Gabriel, D. A. (2009). Coagulopathy of acute liver failure. Clin. Liver Dis. 13 (1), 95–107. doi:10.1016/j.cld.2008.10.001
Nguyen, Q. M., Abouezzi, J., and Ristroph, L. (2021). Early turbulence and pulsatile flows enhance diodicity of Tesla’s macrofluidic valve. Nat. Commun. 12 (1), 2884. doi:10.1038/s41467-021-23009-y
Prusa, V. (2008). On the influence of boundary condition on stability of Hagen—Poiseuille flow. Computers&Mathematics Appl. 57 (5), 763–771. doi:10.1016/j.camwa.2008.09.043
Rubio, A., López, M., Rodrigues, T., Campo-Deaño, L., and Vega, E. J. (2022). A particulate blood analogue based on artificial viscoelastic blood plasma and RBC-like microparticles at a concentration matching the human haematocrit. Soft Matter 18 (39), 7510–7523. doi:10.1039/d2sm00947a
Saha, B., Mathur, T., Tronolone, J. J., Chokshi, M., Lokhande, G. K., Selahi, A., et al. (2021). Human tumor microenvironment chip evaluates the consequences of platelet extravasation and combinatorial antitumor-antiplatelet therapy in ovarian cancer. Sci. Adv. 7 (30), eabg5283. doi:10.1126/sciadv.abg5283
Ting, L. H., Feghhi, S., Taparia, N., Smith, A. O., Karchin, A., Lim, E., et al. (2019). Contractile forces in platelet aggregates under microfluidic shear gradients reflect platelet inhibition and bleeding risk. Nat. Commun. 10 (1), 1204. doi:10.1038/s41467-019-09150-9
Tyagi, T., Jain, K., Gu, S. X., Qiu, M., Gu, V. W., Melchinger, H., et al. (2022). A guide to molecular and functional investigations of platelets to bridge basic and clinical sciences. Nat. Cardiovasc. Res. 1 (3), 223–237. doi:10.1038/s44161-022-00021-z
Valeanu, L., Ginghina, C., and Bubenek-Turconi, S. (2021). Blood rheology alterations in patients with cardiovascular diseases. Romanian J. Anaesth. Intensive Care 28 (2), 41–46. doi:10.2478/rjaic-2021-0007
Wang, J., Cui, B., Liu, H., Chen, X., Li, Y., Wang, R., et al. (2022). Tesla valve-based flexible microhybrid chip with unidirectional flow properties. ACS Omega 7 (36), 31744–31755. doi:10.1021/acsomega.2c02075
Wen, F., Liu, Y., and Wang, H. (2022). Clinical evaluation tool for vascular health– endothelial function and cardiovascular disease management. Cells 11, 3363. doi:10.3390/cells11213363
Wu, Z., Ao, Z., Cai, H., Li, X., Chen, B., Tu, H., et al. (2023a). Acoustofluidic assembly of primary tumor-derived organotypic cell clusters for rapid evaluation of cancer immunotherapy. J. Nanobiotechnology 21 (1), 40. doi:10.1186/s12951-023-01786-6
Wu, Z., Cai, H., Ao, Z., Nunez, A., Liu, H., Bondesson, M., et al. (2019). A digital acoustofluidic pump powered by localized fluid-substrate interactions. Anal. Chem. 91 (11), 7097–7103. doi:10.1021/acs.analchem.9b00069
Wu, Z., Pan, M., Wang, J., Wen, B., Lu, L., and Ren, H. (2022). Acoustofluidics for cell patterning and tissue engineering. Eng. Regen. 3 (4), 397–406. doi:10.1016/j.engreg.2022.08.005
Wu, Z., Sun, L., Chen, H., Zhao, Y., Ruan, Q., Huang, C., et al. (2023b). Nanostructured conductive polypyrrole for antibacterial components in flexible wearable devices. Research 6, 0074. doi:10.34133/research.0074
Xie, J., Shih, J., Lin, Q., Yang, B., and Tai, Y.-C. (2004). Surface micromachined electrostatically actuated micro peristaltic pump. Lab a Chip 4 (5), 495–501. doi:10.1039/b403906h
Xu, J., Cai, H., Wu, Z., Li, X., Tian, C., Ao, Z., et al. (2023). Acoustic metamaterials-driven transdermal drug delivery for rapid and on-demand management of acute disease. Nat. Commun. 14 (1), 869. doi:10.1038/s41467-023-36581-2
Yi, H., Yang, Z., Johnson, M., Bramlage, L., and Ludwig, B. (2022). Hemodynamic characteristics in a cerebral aneurysm model using non-Newtonian blood analogues. Phys. Fluids 34 (10), 103101. doi:10.1063/5.0118097
Zhang, T., Yu, S., Wang, B., Xu, Y., Shi, X., Zhao, W., et al. (2022a). A high spatiotemporal iontronic single-cell viscometer. Research 2022, 9859101. doi:10.34133/2022/9859101
Zhang, Y. S., Davoudi, F., Walch, P., Manbachi, A., Luo, X., Dell’Erba, V., et al. (2016). Bioprinted thrombosis-on-a-chip. Lab a Chip 16 (21), 4097–4105. doi:10.1039/c6lc00380j
Keywords: biofabrication, tesla valves, ultrasound wave, viscosity measurement, coagulopathy
Citation: Chen W, Xia M, Zhu W, Xu Z, Cai B and Shen H (2024) A bio-fabricated tesla valves and ultrasound waves-powered blood plasma viscometer. Front. Bioeng. Biotechnol. 12:1394373. doi: 10.3389/fbioe.2024.1394373
Received: 01 March 2024; Accepted: 11 April 2024;
Published: 24 April 2024.
Edited by:
Kaushik Chatterjee, Indian Institute of Science (IISc), IndiaReviewed by:
Junhua Xu, West China Hospital, Sichuan University, ChinaPeng Li, West Virginia University, United States
Copyright © 2024 Chen, Xia, Zhu, Xu, Cai and Shen. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Zhiye Xu, xuzhiye@sina.com; Bo Cai, bcai@jhun.edu.cn; Han Shen, shenhan@njglyy.com